Physician
Addiction Angels of America, LLC
Addiction Angels of America, LLC was paid $3.31M by Medicaid between Jan 2018 and Nov 2024, across 43 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoADDICTION ANGELS OF AMERICA, LLC
COLUMBUS, OH 43229
COLUMBUS, OH 43229
33aNPI1396148375assigned 10/03/2014
33bProvider typeAddiction Medicine (Internal Medicine) Physician
28Total paid$3.31M
24GClaims105,923
24DCodes billed43
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Addiction Medicine (Internal Medicine) Physician providers in Ohio
Rank by total paid#3 of 10
Median peer was paid$73K
This provider vs. median45×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,560 | $241K | |
| 2019 | 20,003 | $430K | |
| 2020 | 51,471 | $1.06M | |
| 2021 | 11,644 | $749K | |
| 2022 | 5,997 | $353K | |
| 2023 | 5,155 | $305K | |
| 2024incomplete | 3,093 | $179K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 16,009 | 10,739 | $976K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 16% | 10,728 | 6,532 | $535K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 13% | 3,257 | 2,908 | $440K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 7.6% | 8,766 | 6,745 | $251K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.5% | 6,104 | 3,950 | $247K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 4.6% | 3,748 | 2,897 | $152K |
| 80346 | 1.7% | 2,660 | 1,962 | $57K | |
| 80361 | 1.5% | 2,684 | 1,950 | $49K | |
| 80362 | 1.4% | 2,553 | 1,875 | $47K | |
| 83992 | 1.2% | 2,741 | 2,022 | $40K | |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.0% | 378 | 319 | $34K |
| 80348 | <1% | 2,943 | 2,109 | $30K |
31 more codes
| 80349 | <1% | 2,818 | $29K | |
| 80353 | <1% | 2,779 | $28K | |
| 80360 | <1% | 2,757 | $28K | |
| 80355 | <1% | 2,749 | $28K | |
| 80366 | <1% | 2,734 | $28K | |
| 80354 | <1% | 2,702 | $28K | |
| 80365 | <1% | 2,654 | $27K | |
| 80324 | <1% | 2,636 | $27K | |
| 80372 | <1% | 2,619 | $27K | |
| 80359 | <1% | 2,618 | $27K | |
| 80305 | <1% | 4,678 | $26K | |
| 80373 | <1% | 2,443 | $25K | |
| 80358 | <1% | 2,224 | $23K | |
| 80370 | <1% | 2,156 | $22K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 198 | $16K |
| 99205 | Prolong outpt/office vis | <1% | 160 | $15K |
| 80335 | <1% | 1,035 | $11K | |
| 80336 | <1% | 1,069 | $10K | |
| 80363 | <1% | 342 | $6K | |
| 80356 | <1% | 461 | $5K | |
| 80368 | <1% | 378 | $4K | |
| 80345 | <1% | 339 | $3K | |
| 80323 | <1% | 356 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 28 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 21 | $2K |
| 90836 | <1% | 31 | $1K | |
| 80502 | <1% | 100 | $1K | |
| 81025 | <1% | 207 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 13 | $536.78 |
| 80306 | <1% | 32 | $431.04 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15 | $32.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARCIA, ROGER (PRESIDENT)